Parmax Pharma Ltd - PARMAX PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE240T01014

Parmax Pharma Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/18/2024 12:00:00 AM

    ₹ 31.5 -0.39 -1.22
  • Open
  • ₹ 32.5
  • Prev. Close
  • ₹ 31.89
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 32.5
  • Day's Low
  • ₹ 30.4
  • 52 Week's High
  • ₹ 36.58
  • 52 Week's Low
  • ₹ 24.18
  • Book Value
  • ₹ 6.617
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 11.79
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Parmax Pharma Ltd Corporate Actions

07 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2024

12:00 AM

03 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2023

12:00 AM

16 Aug , 2023

12:00 AM

AGM

Announcement date: 16 Aug , 2023

View Details

07 Aug , 2023

12:00 AM

07 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Parmax Pharma Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT
19 April , 2024 | 02:37 AM

PROMOTER - TOTAL30.83%

Indian: 30.83%

Foreign: 0%

NON-PROMOTER - TOTAL 69.17%

Institutions: 0.00%

Non-Institutions: 69.17%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Parmax Pharma Ltd FINANCIALS

No Data Available To Display Chart

Parmax Pharma Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Parmax Pharma Ltd

  • Umang Alkesh Gosalia
  • Managing Director
  • Ami R Shah
  • Non-Exec. & Independent Dir.
  • Yash Vora
  • Company Sec. & Compli. Officer
  • Nikhil S. Uchat
  • Independent Director
Company FAQ

No Record Found